advertisement

WGA Rescources

Advances in Therapy 15

Showing records 1 to 15 | Display all abstracts in Advances in Therapy

80509 Enhancement of Retinal Function and of Neural Conduction Along the Visual Pathway Induced by Treatment with Citicoline Eye Drops in Liposomal Formulation in Open Angle Glaucoma: A Pilot Electrofunctional Study
Parisi V
Advances in Therapy 2019; 36: 987-996
80545 Case Series of Combined iStent Implantation and Phacoemulsification in Eyes with Primary Angle Closure Disease: One-Year Outcomes
Hernstadt DJ
Advances in Therapy 2019; 36: 976-986
81112 Second-Generation Trabecular Micro-Bypass Stents as Standalone Treatment for Glaucoma: A 36-Month Prospective Study
Hengerer FH; Auffarth GU
Advances in Therapy 2019; 36: 1606-1617
80545 Case Series of Combined iStent Implantation and Phacoemulsification in Eyes with Primary Angle Closure Disease: One-Year Outcomes
Cheng J
Advances in Therapy 2019; 36: 976-986
80509 Enhancement of Retinal Function and of Neural Conduction Along the Visual Pathway Induced by Treatment with Citicoline Eye Drops in Liposomal Formulation in Open Angle Glaucoma: A Pilot Electrofunctional Study
Oddone F
Advances in Therapy 2019; 36: 987-996
80545 Case Series of Combined iStent Implantation and Phacoemulsification in Eyes with Primary Angle Closure Disease: One-Year Outcomes
Htoon HM
Advances in Therapy 2019; 36: 976-986
81112 Second-Generation Trabecular Micro-Bypass Stents as Standalone Treatment for Glaucoma: A 36-Month Prospective Study
Riffel C
Advances in Therapy 2019; 36: 1606-1617
80509 Enhancement of Retinal Function and of Neural Conduction Along the Visual Pathway Induced by Treatment with Citicoline Eye Drops in Liposomal Formulation in Open Angle Glaucoma: A Pilot Electrofunctional Study
Roberti G
Advances in Therapy 2019; 36: 987-996
80545 Case Series of Combined iStent Implantation and Phacoemulsification in Eyes with Primary Angle Closure Disease: One-Year Outcomes
Sangtam T
Advances in Therapy 2019; 36: 976-986
81112 Second-Generation Trabecular Micro-Bypass Stents as Standalone Treatment for Glaucoma: A 36-Month Prospective Study
Conrad-Hengerer I
Advances in Therapy 2019; 36: 1606-1617
80509 Enhancement of Retinal Function and of Neural Conduction Along the Visual Pathway Induced by Treatment with Citicoline Eye Drops in Liposomal Formulation in Open Angle Glaucoma: A Pilot Electrofunctional Study
Tanga L
Advances in Therapy 2019; 36: 987-996
80545 Case Series of Combined iStent Implantation and Phacoemulsification in Eyes with Primary Angle Closure Disease: One-Year Outcomes
Sangtam T; Thomas A
Advances in Therapy 2019; 36: 976-986
80509 Enhancement of Retinal Function and of Neural Conduction Along the Visual Pathway Induced by Treatment with Citicoline Eye Drops in Liposomal Formulation in Open Angle Glaucoma: A Pilot Electrofunctional Study
Carnevale C; Carnevale C
Advances in Therapy 2019; 36: 987-996
80545 Case Series of Combined iStent Implantation and Phacoemulsification in Eyes with Primary Angle Closure Disease: One-Year Outcomes
Sng CCA
Advances in Therapy 2019; 36: 976-986
80509 Enhancement of Retinal Function and of Neural Conduction Along the Visual Pathway Induced by Treatment with Citicoline Eye Drops in Liposomal Formulation in Open Angle Glaucoma: A Pilot Electrofunctional Study
Ziccardi L; Manni G
Advances in Therapy 2019; 36: 987-996

Issue 20-3

Change Issue


advertisement

WGA Rescources